ArticleResearch integrity and peer review2026
From concept to measurement: operationalizing and normalizing Integrity Risk Indicators by SCImago (IRIS).
Article in Research integrity and peer review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Integrity Risk Indicators by SCImago (IRIS) framework, developed by the SCImago Research Group, addresses growing concerns about trust in science by shifting research assessment from traditional output and citation-based measures toward the evaluation of institutional exposure to research integrity risks. Rather than focusing on individual misconduct, IRIS recognizes the central role of institutional incentive systems, governance structures, and operational cultures in shaping research integrity. IRIS provides a constructive, data-informed model for identifying structural vulnerabilities associated with practices such as authorship and affiliation patterns, dissemination and citation dynamics, publication venue credibility, and the sustainability and transparency of publication practices. The indicators are derived from bibliometric and publication data and are intended as signals of potential risk, not as diagnoses or judgments. Applied to Higher Education Institutions included in the SCImago Institutions Rankings, IRIS enables meaningful comparison through z-score normalization, placing heterogeneous indicators on a common, interpretable scale centered on the global mean. The use of standardized scores enhances sensitivity to the magnitude of deviations, allowing IRIS to better function as a risk detection system, rather than a competitive ranking, and to support institutions in strengthening responsible and trustworthy research environments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.